Immunic Inc. (IMUX) Tops Q1 EPS by 6c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/2/2026

1. CRWD
2. REGN
3. LYB
4. TFII
5. LITE
6. CL
7. RELIANCE:I
8. BP
9. ABBV
10. CVX

Go back to Immunic Inc. (IMUX) Tops Q1 EPS by 6c

Immunic, Inc. Reports First Quarter 2022 Financial Results and Provides Corporate Update

May 10, 2022 6:30 AM EDT

Top-Line Data from Phase 2 CALDOSE-1 Trial of Vidofludimus Calcium in Moderate-to-Severe Ulcerative Colitis Expected Next Month

Part C Portion of Phase 1 Trial of IMU-935 in Psoriasis Patients Ongoing; Data Expected in the Second Half of 2022

Current Cash and Cash Equivalents Expected to Fund Immunic Into the Third Quarter of 2023

Webcast to be Held Today, May 10, 2022, at 8:00 am ET

NEW YORK, May 10, 2022 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage... More